Novavax Inc (NVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 09-2010 | 06-2010 | 03-2010 | 12-2009 | |
| Sales | 51 | 175 | 7 | 110 | 74 |
| Gross Profit | 51 | 175 | 7 | 110 | 74 |
| Operating Expenses | 7,084 | 10,714 | 9,475 | 11,564 | 14,228 |
| Operating Income | -7,033 | -10,539 | -9,468 | -11,454 | -14,154 |
| Interest Expense | 3 | 2 | 2 | 2 | 4 |
| Other Income | 436 | 183 | 613 | 1,113 | -1,769 |
| Pre-tax Income | -6,600 | -10,358 | -8,857 | -10,343 | -15,927 |
| Income Tax | -314 | -136 | N/A | N/A | N/A |
| Net Income Continuous | -6,286 | -10,222 | -8,857 | -10,343 | -15,927 |
| Net Income | $-6,286 | $-10,222 | $-8,857 | $-10,343 | $-15,927 |
| EPS Basic Total Ops | -1.00 | -2.00 | -1.80 | -2.00 | -3.40 |
| EPS Basic Continuous Ops | -1.08 | -1.91 | -1.76 | -2.06 | -3.36 |
| EPS Diluted Total Ops | -1.00 | -2.00 | -1.80 | -2.00 | -3.40 |
| EPS Diluted Continuous Ops | -1.08 | -1.91 | -1.76 | -2.06 | -3.36 |
| EBITDA(a) | $-6,539 | $-10,113 | $-9,065 | $-11,158 | $-13,859 |